China Medical System to pay Insilico up to $177 million for nervous system work

China Medical System will pay Insilico Medicine up to ~1.2 billion yuan ($177 million) in milestone payments for a central nervous system R&D program. The deal size is material for funding and validates the drug discovery effort, which should be modestly supportive for expectations around future progress and commercialization.

Analysis

China Medical System will pay Insilico Medicine up to ~1.2 billion yuan ($177 million) in milestone payments for a central nervous system R&D program. The deal size is material for funding and validates the drug discovery effort, which should be modestly supportive for expectations around future progress and commercialization.